Type II hypersensitivity

Jump to: navigation, search

WikiDoc Resources for

Type II hypersensitivity

Articles

Most recent articles on Type II hypersensitivity

Most cited articles on Type II hypersensitivity

Review articles on Type II hypersensitivity

Articles on Type II hypersensitivity in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Type II hypersensitivity

Images of Type II hypersensitivity

Photos of Type II hypersensitivity

Podcasts & MP3s on Type II hypersensitivity

Videos on Type II hypersensitivity

Evidence Based Medicine

Cochrane Collaboration on Type II hypersensitivity

Bandolier on Type II hypersensitivity

TRIP on Type II hypersensitivity

Clinical Trials

Ongoing Trials on Type II hypersensitivity at Clinical Trials.gov

Trial results on Type II hypersensitivity

Clinical Trials on Type II hypersensitivity at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Type II hypersensitivity

NICE Guidance on Type II hypersensitivity

NHS PRODIGY Guidance

FDA on Type II hypersensitivity

CDC on Type II hypersensitivity

Books

Books on Type II hypersensitivity

News

Type II hypersensitivity in the news

Be alerted to news on Type II hypersensitivity

News trends on Type II hypersensitivity

Commentary

Blogs on Type II hypersensitivity

Definitions

Definitions of Type II hypersensitivity

Patient Resources / Community

Patient resources on Type II hypersensitivity

Discussion groups on Type II hypersensitivity

Patient Handouts on Type II hypersensitivity

Directions to Hospitals Treating Type II hypersensitivity

Risk calculators and risk factors for Type II hypersensitivity

Healthcare Provider Resources

Symptoms of Type II hypersensitivity

Causes & Risk Factors for Type II hypersensitivity

Diagnostic studies for Type II hypersensitivity

Treatment of Type II hypersensitivity

Continuing Medical Education (CME)

CME Programs on Type II hypersensitivity

International

Type II hypersensitivity en Espanol

Type II hypersensitivity en Francais

Business

Type II hypersensitivity in the Marketplace

Patents on Type II hypersensitivity

Experimental / Informatics

List of terms related to Type II hypersensitivity


In type II hypersensitivity (or cytotoxic hypersensitivity)[1] the antibodies produced by the immune response bind to antigens on the patient's own cell surfaces. The antigens recognized in this way may either be intrinsic ("self" antigen, innately part of the patient's cells) or extrinsic (absorbed onto the cells during exposure to some foreign antigen, possibly as part of infection with a pathogen). These cells are recognized by macrophages or dendritic cells which act as antigen presenting cells, this causes a B cell response where antibodies are produced against the foreign antigen.

An example here is the reaction to penicillin where the drug can bind to red blood cells causing them to be recognised as different, B cell proliferation will take place and antibodies to the drug are produced. IgG and IgM antibodies bind to these antigens to form complexes that activate the classical pathway of complement activation to eliminate cells presenting foreign antigens (which are usually, but not in this case, pathogens). That is, mediators of acute inflammation are generated at the site and membrane attack complexes cause cell lysis and death. The reaction takes hours to a day.

Another form of type 2 hypersensitivity is called antibody-dependent cell-mediated cytotoxicity (ADCC). Here, cells exhibiting the foreign antigen are tagged with antibodies (IgG or IgM). These tagged cells are then recognised by natural killer (NK) cells and macrophages (recognised via IgG bound (via the Fc region) to the effector cell surface receptor, CD16 (FcγRIII)), which in turn kill these tagged cells.

Some examples

References


Linked-in.jpg